In conclusion, to our knowledge, this is the first study to rigorously compare the prevalence of the most common molecular subtypes of primary prostate cancer between HOXB13 G84E carriers and non-carriers, matched for relevant clinical-pathologic variables. The gene discussed is HOXB13; the disease is Familial prostate cancer.